Pricing Log in Create free account

Anebulo Pharmaceuticals, Inc. (ANEB) vs Psyence Biomedical Ltd. (PBM)

Anebulo Pharmaceuticals, Inc. and Psyence Biomedical Ltd. are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Psyence Biomedical Ltd. are of similar size ($17.6M and $16.5M). Anebulo Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Psyence Biomedical Ltd. trades at 0.2×. Across the 8 metrics below, Psyence Biomedical Ltd. leads on 5 and Anebulo Pharmaceuticals, Inc. on 3.

Valuation

Metric ANEB PBM Biotechnology median
P/E n/m 0.19 8.50
P/S n/m n/m 9.71
P/B n/m 0.08 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.03 1.82 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% 534.77% (33.15%)
Free cash flow yield 0.00% (807.70%) (25.50%)

Profitability

Metric ANEB PBM Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.69%) (23.52%) (56.36%)
Return on assets (63.17%) (6.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANEB PBM Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 21.88% (138.35%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANEB PBM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.24 8.09 4.72
Net debt to EBITDA 1.32 1.20 0.96

Dividend

Metric ANEB PBM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANEB PBM Biotechnology median
Market cap 17.60m 16.47m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack